CG
Chris Garabedian
Angel InvestorModerateChris Garabedian founded Xontogeny in June of 2016 to support multiple promising technologies from early development through clinical proof ...
9
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Chris Garabedian.
Investment Thesis & Strategy
Chris Garabedian invests in various stages of development for promising technologies across multiple industries, with a focus on early-stage clinical proof.
Investment Activity
Deals per year over the last 6 years
1
20161
20171
20182
20192
20202
2021Portfolio Companies
Selected investments from their portfolio of 9 companies
P
Peroxitech Therapeutics
Biotech · Seed, 2021
N
Nephraegis Therapeutics
Biotech · Seed, 2021
T
Tellus Therapeutics
Biotech · Seed, 2020
S
Shifa Biomedical
Biotech · Seed, 2020
J
Juno Diagnostics
Biotech · Seed, 2019
A
AsclepiX Therapeutics
Biotech · Seed, 2019
Z
Zucara Therapeutics
Biotech · Seed, 2018
C
CereVasc
Biotech · Seed, 2017
L
Landos Biopharma
Biotech · Seed, 2016
Frequently Asked Questions
Chris Garabedian focuses on Seed, Pre-seed stage investments.